Release Date: 10/11/21 08:49 Summary: Andromeda and Minotaur to Combine Price Sensitive: Yes Download Document 1.21MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%